EUVIMEDEUVIMED entdecken
Crossref

Parameters to assess the necessity of adjuvant therapy for early‐stage oral squamous cell carcinoma

Hsueh-Ju Lu iD, Yu-Wei Chiu, Chih-Yu Peng, Hsien-Chun Tseng, Chung-Han Hsin, Chun-Yi Chuang, Sheng Fan, Wei-Shiou Huang, Shun-Fa Yang iD

Oral Diseases · 2025

DOI: 10.1111/odi.15123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Hsueh-Ju Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Chemoradiotherapy, Adjuvant. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Chung Shan Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

One‐third of head and neck squamous cell carcinomas are early‐stage oral cavity squamous cell carcinomas (OCSCC). Despite a high curative rate, 20% of early‐stage OCSCC patients do not achieve long‐term survival. This study evaluates the role of adjuvant therapy (ADJ) in delaying disease progression and prolonging survival.

Methods

This single‐institute retrospective cohort study enrolled 481 early‐stage OCSCC patients, 16% (78/481) of whom received ADJ. It was reported according to the STROBE guidelines. Cox proportional hazards regression and Kaplan–Meier survival curves were employed to identify suitable candidates for ADJ.

Results

The 5‐year locoregional recurrence‐free survival (LR‐RFS) and overall survival rates were 73.2% and 84.9%, respectively. Positive margins and advanced depth of invasion (DOI) were independent predictors of LR‐RFS. For patients with positive margins, adjuvant chemoradiotherapy (CRT) was superior to adjuvant radiotherapy alone in improving LR‐RFS (hazard ratios for adjuvant CRT vs. none, 0.042; adjuvant radiotherapy alone vs. none, 0.702). Excluding positive margins, advanced DOI was the most critical factor in assessing the need for ADJ. Positive margins and advanced DOI were more appropriate criteria than EORTC 22931/RTOG 9501 for evaluating adjuvant CRT.

Conclusions

Adjuvant CRT was indicated for patients with positive margins and advanced DOI to improve survival outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsCarcinoma, Squamous CellChemoradiotherapy, AdjuvantHumansRetrospective StudiesMaleFemaleMiddle AgedAgedRadiotherapy, AdjuvantNeoplasm StagingAdultMargins of ExcisionSurvival RateAged, 80 and overNeoplasm Recurrence, LocalKaplan-Meier Estimate

Stichwörter der Autor:innen

adjuvant/methodschemoradiotherapymargins of excision*mouth neoplasms/pathologyneoplasm invasivenessneoplasm stagingprognosissquamous cell carcinoma of head and Neck

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
  • Department of Radiation Oncology, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Department of Otolaryngology, Chung Shan Medical University Hospital, Taichung, Taiwan.

ORCID-Profile: Hsueh-Ju Lu, Shun-Fa Yang

Förderung

  • Chung Shan Medical University Hospital

Zitieren

APA

Lu, H. J., Chiu, Y. W., Peng, C. Y., Tseng, H. C., Hsin, C. H., Chuang, C. Y., Fan, S., Huang, W. S., & Yang, S. F. (2025). Parameters to assess the necessity of adjuvant therapy for early‐stage oral squamous cell carcinoma. Oral Diseases. https://doi.org/10.1111/odi.15123

Vancouver

Lu HJ, Chiu YW, Peng CY, Tseng HC, Hsin CH, Chuang CY, et al. Parameters to assess the necessity of adjuvant therapy for early‐stage oral squamous cell carcinoma. Oral Diseases. 2025. doi:10.1111/odi.15123

BibTeX
@article{Lu2025,
  author = {Lu, Hsueh-Ju and Chiu, Yu-Wei and Peng, Chih-Yu and Tseng, Hsien-Chun and Hsin, Chung-Han and Chuang, Chun-Yi and Fan, Sheng and Huang, Wei-Shiou and Yang, Shun-Fa},
  title = {Parameters to assess the necessity of adjuvant therapy for early‐stage oral squamous cell carcinoma},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.15123}
}
Kostenlos starten →